Cobalt-binding protein (CoBP)

Cobalt-binding proteins represent a diverse group of molecules that utilize cobalt as a critical metal cofactor for structural stability or catalytic activity. The most prominent examples in human physiology are the cobalamin-binding proteins, such as intrinsic factor and transcobalamin, which are essential for the absorption and transport of Vitamin B12 (cobalamin) (UniProt: P20062). Additionally, certain enzymes like Methionine aminopeptidase 2 (MetAP2) require cobalt or other divalent metals for their proteolytic activity, playing a significant role in protein processing and angiogenesis (PubMed: 15591231). In clinical practice, these proteins are targeted primarily through the administration of cobalamin derivatives to treat deficiency states like pernicious anemia (NIH: Vitamin B12 Fact Sheet). Furthermore, MetAP2 has emerged as a therapeutic target for cancer and obesity, with inhibitors designed to disrupt its role in cell proliferation and metabolic regulation (PubMed: 26933031). Understanding the coordination chemistry and specificity of cobalt binding is essential for developing selective ligands and avoiding systemic cobalt toxicity (StatPearls: Cobalt Toxicity). These proteins also include bacterial enzymes like nitrile hydratase, which are utilized in industrial biocatalysis (PubMed: 11563486). Overall, this class of proteins is vital for one-carbon metabolism and cellular signaling pathways.

Other names

Cobalamin-binding proteinCorrinoid-binding proteinCobalt-dependent enzymeCobalt-containing proteinCobalamin-binding proteins

Drugs targeting cobalt-binding proteins generally act as exogenous cofactors to restore metabolic function in deficiency states or as enzyme inhibitors that bind to the metal-containing active site to block catalytic processes such as protein N-terminal methionine excision.